Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) entered into a licensing agreement with a partner in Oklahoma to produce and distribute Irwin Naturals THC products.
Short-acting psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF)’s proprietary intravenous (IV) DMT-based drug SPL026 delivered positive topline results in a Phase 2a trial for the treatment of Major Depressive Disorder (MDD).
Body and Mind Inc. (OTCQB: BMMJ) (CSE:BAMM) released financial results for the first quarter of fiscal year 2023 ended October 31, 2022, revealing revenue of $7.8 million, a 3.4% increase over Q1 FY 2022 revenues of $7.6 million.